Effect of L-dopa therapy on urinary p-tyramine excretion and EEG changes in Parkinson's disease.
D001921:Brain / Q000503:physiopathology; D002247:Carbon Isotopes; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004569:Electroencephalography; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology / Q000652:urine; D010648:Phenylacetates / Q000652:urine; D014363:Tryptamines / Q000652:urine; D014439:Tyramine / Q000008:administration & dosage / Q000652:urine*
D002247:Carbon Isotopes; D010648:Phenylacetates; D014363:Tryptamines; D004295:Dihydroxyphenylalanine; D014439:Tyramine